[18F]3F-PHPG
- Generic Name
- [18F]3F-PHPG
Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors
Early Phase 1
Completed
- Conditions
- Neuroendocrine Tumors
- Interventions
- Diagnostic Test: Positron emission tomography/computed tomography scanDiagnostic Test: Planar scintigraphy scanDiagnostic Test: Single photon emission computed tomography/computed tomography scan
- First Posted Date
- 2020-08-12
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- University of Michigan Rogel Cancer Center
- Target Recruit Count
- 32
- Registration Number
- NCT04510311
- Locations
- 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
An Exploratory Study of 18F-Labeled Hydroxyphenethylguanidines in Heart Failure Patients
Early Phase 1
Completed
- Conditions
- Cardiomyopathy
- Interventions
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2017-02-27
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 16
- Registration Number
- NCT02669563
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines
Early Phase 1
Completed
- Conditions
- Autonomic Peripheral Nervous System Diseases
- Interventions
- First Posted Date
- 2015-03-11
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 16
- Registration Number
- NCT02385877
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath